1. Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift
   Alessandra Fabbri et al, 2017, Virchows Archiv CrossRef
2. Treatment, prognostic markers, and survival in thymic neuroendocrine tumors
   Kefeng Ma et al, 2017, Medicine CrossRef
3. Long survival and recurrence of thymic carcinoma 10 years after resection
   Hiroshi Yabuki et al, 2019, Asian Cardiovascular and Thoracic Annals CrossRef
4. Successful treatment of advanced thymic carcinoma with lymph node and pleural metastases: A case report
   Yoko Yamamoto et al, 2016, Molecular and Clinical Oncology CrossRef